COPD・喘息用デバイス市場：製品タイプ、用途、エンドユーザー、流通チャネル別-2025～2030年の世界予測

COPD・喘息用デバイス市場は、2023年に353億3,000万米ドルと評価され、2024年には374億5,000万米ドルに達すると予測され、CAGR 5.93％で成長し、2030年には529億米ドルに達すると予測されています。

COPD・喘息機器市場には、慢性閉塞性肺疾患（COPD）と喘息の診断、治療、管理のために設計された医療機器や装置が含まれます。これには、吸入器、ネブライザー、酸素濃縮器、スパイロメトリー装置などが含まれ、臨床や在宅環境には欠かせないです。これらの機器の必要性は、公害、喫煙、高齢化などの要因による呼吸器疾患の有病率の増加から生じています。これらの機器は、効率的な薬剤投与、呼吸状態のモニタリング、患者のQOL向上に極めて重要です。呼吸器の健康に対する意識の高まりと医療技術の進歩が、先進国市場と新興国市場の両方で需要を牽引しています。主な成長要因には、スマート吸入器や携帯型ネブライザーなどの技術革新、ヘルスケア支出の増加、呼吸器ケアを推進する政府の支援政策などがあります。最新のビジネスチャンスは、アプリやIoT対応デバイスを通じて患者のアドヒアランスやモニタリングを強化するデジタルヘルス技術の統合にあります。メーカー各社は研究開発に投資し、ハイテクに精通した患者に対応する、より使いやすく接続性の高いデバイスを開発することで、これを活用することができます。しかし、この市場は、先進デバイスの高コスト、規制当局の厳しい承認、低所得地域でのアクセス制限といった課題に直面しています。さらに、ヘルスケアインフラの格差が新興国における市場成長の妨げになる可能性もあります。イノベーションに注力する企業は、こうした障壁を克服するために、費用対効果の高い製造プロセスを検討し、市場参入を拡大するためのパートナーシップを模索する必要があります。また、患者固有のニーズに対応するため、機器の有効性を高め、副作用を軽減することを目標に調査する必要があります。市場競争は依然として激しく、M&Aによる製品ポートフォリオの拡充を目指す企業の統合動向も見られます。全体として、業界は進化を続けており、COPD・喘息治療機器市場の成長機会をもたらす、患者中心のイノベーションとデジタルイノベーションには十分な開拓余地があります。

市場力学：急速に進化するCOPD・喘息用デバイス市場の主要市場インサイトを公開

COPD・喘息用デバイス市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 呼吸器疾患の管理と治療を支援する政府の取り組みと政策
  • 医療アクセスの向上を通じて呼吸器機器メーカーに新たな機会をもたらす新興市場
  • ユーザーフレンドリーで携帯可能な機器設計による、呼吸器治療に対する患者のアドヒアランス向上
  • 呼吸器疾患を悪化させる環境汚染の増加と治療機器に対する需要の増加
• 市場抑制要因
  • COPDおよび喘息デバイス製造における標準化の欠如が製品の一貫性に影響
  • COPD・喘息治療機器の最新進歩に関するヘルスケアプロバイダーへの教育課題
• 市場機会
  • COPDおよび喘息治療プロトコールにおける個別化医療アプローチの台頭
  • 喘息による入院を減らすための患者教育および自己管理プログラムの成長
  • COPD治療における服薬アドヒアランスを高める革新的ドラッグデリバリーシステム
• 市場の課題
  • 患者の服薬アドヒアランスの確保と処方された治療レジメンの遵守における複雑さ
  • 農村部や医療が行き届いていない地域でのヘルスケアアクセスの制限

ポーターの5つの力：COPD・喘息用デバイス市場をナビゲートする戦略ツール

ポーターのファイブフォース（5つの力）は、市場情勢の競合情勢を把握するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：COPD・喘息用デバイス市場における外部からの影響の把握

外部マクロ環境要因は、COPD・喘息用デバイス市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析COPD・喘息用デバイス市場における競合情勢の把握

COPD・喘息用デバイス市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスCOPD・喘息用デバイス市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、COPD・喘息用デバイス市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨COPD・喘息用デバイス市場における成功への道筋を描く

COPD・喘息用デバイス市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 呼吸器疾患の管理と治療を支援する政府の取り組みと政策
    • 新興市場はヘルスケアへのアクセス強化を通じて呼吸器メーカーに新たな機会を創出
    • 使いやすくポータブルなデバイス設計により、呼吸療法に対する患者の遵守が向上
    • 環境汚染の増加により呼吸器疾患が悪化し、治療機器の需要が増加
  • 抑制要因
    • COPDおよび喘息デバイス製造における標準化の欠如が製品の一貫性に影響
    • 最新のCOPDおよび喘息治療機器の進歩についてヘルスケア従事者に教育する際の課題
  • 機会
    • COPDおよび喘息治療プロトコルにおける個別化医療アプローチの台頭
    • 喘息関連の入院を減らすための患者教育と自己管理プログラムの増加
    • COPD治療における服薬遵守を強化する革新的なドラッグデリバリーシステム
  • 課題
    • 処方された治療計画に対する患者の遵守とコンプライアンスを確保する際の合併症
    • 農村部や医療サービスが行き届いていない地域ではヘルスケアへのアクセスが限られている
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTLE分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 COPD・喘息用デバイス市場：製品タイプ別

• アクセサリー
  • アクチュエータ
  • ドライパウダー吸入器ロータキャップとカートリッジ
  • スペーサー
• 吸入器
  • ドライパウダー吸入器（DPI）
  • 定量噴霧式吸入器（MDI）
  • ソフトミスト吸入器
• ネブライザー
  • ジェットネブライザー
  • メッシュネブライザー
  • 超音波ネブライザー

第7章 COPD・喘息用デバイス市場：用途別

• 喘息
  • アレルギー性喘息
  • 運動誘発性喘息
  • 非アレルギー性喘息
• 慢性閉塞性肺疾患（COPD）
  • 慢性気管支炎
  • 肺気腫

第8章 COPD・喘息用デバイス市場：エンドユーザー別

• 外来手術センター
• ホームケア設定
• 病院・クリニック
• 専門クリニック

第9章 COPD・喘息用デバイス市場：流通チャネル別

• 病院薬局
• オンライン薬局
• 小売薬局

第10章 南北アメリカのCOPD・喘息用デバイス市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域のCOPD・喘息用デバイス市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカのCOPD・喘息用デバイス市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• 1. 3M Health Care
• 2. Aerogen
• 3. Air Liquide Healthcare
• 4. Becton, Dickinson and Company
• 5. Chart Industries
• 6. Drive DeVilbiss Healthcare
• 7. Fisher & Paykel Healthcare
• 8. Getinge
• 9. GF Health Products, Inc.
• 10. Hamilton Medical
• 11. Invacare Corporation
• 12. Koninklijke Philips N.V.
• 13. Medtronic
• 14. Nihon Kohden Corporation
• 15. PARI Medical Holding
• 16. ResMed
• 17. Smiths Medical
• 18. SunMed
• 19. Teleflex Incorporated

LIST OF FIGURES

• FIGURE 1. COPD & ASTHMA DEVICES MARKET RESEARCH PROCESS
• FIGURE 2. COPD & ASTHMA DEVICES MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS COPD & ASTHMA DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS COPD & ASTHMA DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES COPD & ASTHMA DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES COPD & ASTHMA DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC COPD & ASTHMA DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC COPD & ASTHMA DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA COPD & ASTHMA DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA COPD & ASTHMA DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. COPD & ASTHMA DEVICES MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. COPD & ASTHMA DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. COPD & ASTHMA DEVICES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. COPD & ASTHMA DEVICES MARKET DYNAMICS
• TABLE 7. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY ACTUATORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY DRY POWDER INHALER ROTACAPS & CARTRIDGES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY SPACERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY DRY POWDER INHALERS (DPI), BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY METERED-DOSE INHALERS (MDI), BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY SOFT MIST INHALERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY JET NEBULIZERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY MESH NEBULIZERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY ULTRASONIC NEBULIZERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY ALLERGIC ASTHMA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY EXERCISE-INDUCED ASTHMA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY NON-ALLERGIC ASTHMA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC BRONCHITIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY EMPHYSEMA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 35. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 36. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 37. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 38. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 39. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 40. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 41. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 42. AMERICAS COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 43. AMERICAS COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 44. AMERICAS COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
• TABLE 45. AMERICAS COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
• TABLE 46. AMERICAS COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 47. AMERICAS COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
• TABLE 48. AMERICAS COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
• TABLE 49. AMERICAS COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 50. AMERICAS COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 51. AMERICAS COPD & ASTHMA DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 52. ARGENTINA COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 53. ARGENTINA COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 54. ARGENTINA COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
• TABLE 55. ARGENTINA COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
• TABLE 56. ARGENTINA COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 57. ARGENTINA COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
• TABLE 58. ARGENTINA COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
• TABLE 59. ARGENTINA COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 60. ARGENTINA COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 61. BRAZIL COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 62. BRAZIL COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 63. BRAZIL COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
• TABLE 64. BRAZIL COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
• TABLE 65. BRAZIL COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 66. BRAZIL COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
• TABLE 67. BRAZIL COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
• TABLE 68. BRAZIL COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 69. BRAZIL COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 70. CANADA COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 71. CANADA COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 72. CANADA COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
• TABLE 73. CANADA COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
• TABLE 74. CANADA COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 75. CANADA COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
• TABLE 76. CANADA COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
• TABLE 77. CANADA COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 78. CANADA COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 79. MEXICO COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 80. MEXICO COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 81. MEXICO COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
• TABLE 82. MEXICO COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
• TABLE 83. MEXICO COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 84. MEXICO COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
• TABLE 85. MEXICO COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
• TABLE 86. MEXICO COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 87. MEXICO COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 88. UNITED STATES COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 89. UNITED STATES COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 90. UNITED STATES COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
• TABLE 91. UNITED STATES COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
• TABLE 92. UNITED STATES COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 93. UNITED STATES COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
• TABLE 94. UNITED STATES COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
• TABLE 95. UNITED STATES COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 96. UNITED STATES COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 97. UNITED STATES COPD & ASTHMA DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 98. ASIA-PACIFIC COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 99. ASIA-PACIFIC COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 100. ASIA-PACIFIC COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
• TABLE 101. ASIA-PACIFIC COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
• TABLE 102. ASIA-PACIFIC COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 103. ASIA-PACIFIC COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
• TABLE 104. ASIA-PACIFIC COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
• TABLE 105. ASIA-PACIFIC COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 106. ASIA-PACIFIC COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 107. ASIA-PACIFIC COPD & ASTHMA DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 108. AUSTRALIA COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 109. AUSTRALIA COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 110. AUSTRALIA COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
• TABLE 111. AUSTRALIA COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
• TABLE 112. AUSTRALIA COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 113. AUSTRALIA COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
• TABLE 114. AUSTRALIA COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
• TABLE 115. AUSTRALIA COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 116. AUSTRALIA COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 117. CHINA COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 118. CHINA COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 119. CHINA COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
• TABLE 120. CHINA COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
• TABLE 121. CHINA COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 122. CHINA COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
• TABLE 123. CHINA COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
• TABLE 124. CHINA COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 125. CHINA COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 126. INDIA COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 127. INDIA COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 128. INDIA COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
• TABLE 129. INDIA COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
• TABLE 130. INDIA COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 131. INDIA COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
• TABLE 132. INDIA COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
• TABLE 133. INDIA COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 134. INDIA COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 135. INDONESIA COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 136. INDONESIA COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 137. INDONESIA COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
• TABLE 138. INDONESIA COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
• TABLE 139. INDONESIA COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 140. INDONESIA COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
• TABLE 141. INDONESIA COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
• TABLE 142. INDONESIA COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 143. INDONESIA COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 144. JAPAN COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 145. JAPAN COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 146. JAPAN COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
• TABLE 147. JAPAN COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
• TABLE 148. JAPAN COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 149. JAPAN COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
• TABLE 150. JAPAN COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
• TABLE 151. JAPAN COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 152. JAPAN COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 153. MALAYSIA COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 154. MALAYSIA COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 155. MALAYSIA COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
• TABLE 156. MALAYSIA COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
• TABLE 157. MALAYSIA COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 158. MALAYSIA COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
• TABLE 159. MALAYSIA COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
• TABLE 160. MALAYSIA COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 161. MALAYSIA COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 162. PHILIPPINES COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 163. PHILIPPINES COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 164. PHILIPPINES COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
• TABLE 165. PHILIPPINES COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
• TABLE 166. PHILIPPINES COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 167. PHILIPPINES COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
• TABLE 168. PHILIPPINES COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
• TABLE 169. PHILIPPINES COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 170. PHILIPPINES COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 171. SINGAPORE COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 172. SINGAPORE COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 173. SINGAPORE COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
• TABLE 174. SINGAPORE COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
• TABLE 175. SINGAPORE COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 176. SINGAPORE COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
• TABLE 177. SINGAPORE COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
• TABLE 178. SINGAPORE COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 179. SINGAPORE COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 180. SOUTH KOREA COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 181. SOUTH KOREA COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 182. SOUTH KOREA COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
• TABLE 183. SOUTH KOREA COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
• TABLE 184. SOUTH KOREA COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 185. SOUTH KOREA COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
• TABLE 186. SOUTH KOREA COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
• TABLE 187. SOUTH KOREA COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 188. SOUTH KOREA COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 189. TAIWAN COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 190. TAIWAN COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 191. TAIWAN COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
• TABLE 192. TAIWAN COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
• TABLE 193. TAIWAN COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 194. TAIWAN COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
• TABLE 195. TAIWAN COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
• TABLE 196. TAIWAN COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 197. TAIWAN COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 198. THAILAND COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 199. THAILAND COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 200. THAILAND COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
• TABLE 201. THAILAND COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
• TABLE 202. THAILAND COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 203. THAILAND COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
• TABLE 204. THAILAND COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
• TABLE 205. THAILAND COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 206. THAILAND COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 207. VIETNAM COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 208. VIETNAM COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 209. VIETNAM COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
• TABLE 210. VIETNAM COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
• TABLE 211. VIETNAM COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 212. VIETNAM COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
• TABLE 213. VIETNAM COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
• TABLE 214. VIETNAM COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 215. VIETNAM COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 216. EUROPE, MIDDLE EAST & AFRICA COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 217. EUROPE, MIDDLE EAST & AFRICA COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 218. EUROPE, MIDDLE EAST & AFRICA COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
• TABLE 219. EUROPE, MIDDLE EAST & AFRICA COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
• TABLE 220. EUROPE, MIDDLE EAST & AFRICA COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 221. EUROPE, MIDDLE EAST & AFRICA COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
• TABLE 222. EUROPE, MIDDLE EAST & AFRICA COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
• TABLE 223. EUROPE, MIDDLE EAST & AFRICA COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 224. EUROPE, MIDDLE EAST & AFRICA COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 225. EUROPE, MIDDLE EAST & AFRICA COPD & ASTHMA DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 226. DENMARK COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 227. DENMARK COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 228. DENMARK COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
• TABLE 229. DENMARK COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
• TABLE 230. DENMARK COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 231. DENMARK COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
• TABLE 232. DENMARK COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
• TABLE 233. DENMARK COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 234. DENMARK COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 235. EGYPT COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 236. EGYPT COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 237. EGYPT COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
• TABLE 238. EGYPT COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
• TABLE 239. EGYPT COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 240. EGYPT COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
• TABLE 241. EGYPT COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
• TABLE 242. EGYPT COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 243. EGYPT COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 244. FINLAND COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 245. FINLAND COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 246. FINLAND COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
• TABLE 247. FINLAND COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
• TABLE 248. FINLAND COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 249. FINLAND COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
• TABLE 250. FINLAND COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
• TABLE 251. FINLAND COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 252. FINLAND COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 253. FRANCE COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 254. FRANCE COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 255. FRANCE COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
• TABLE 256. FRANCE COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
• TABLE 257. FRANCE COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 258. FRANCE COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
• TABLE 259. FRANCE COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
• TABLE 260. FRANCE COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 261. FRANCE COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 262. GERMANY COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 263. GERMANY COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 264. GERMANY COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
• TABLE 265. GERMANY COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
• TABLE 266. GERMANY COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 267. GERMANY COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
• TABLE 268. GERMANY COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
• TABLE 269. GERMANY COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 270. GERMANY COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 271. ISRAEL COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 272. ISRAEL COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 273. ISRAEL COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
• TABLE 274. ISRAEL COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
• TABLE 275. ISRAEL COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 276. ISRAEL COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
• TABLE 277. ISRAEL COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
• TABLE 278. ISRAEL COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 279. ISRAEL COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 280. ITALY COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 281. ITALY COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 282. ITALY COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
• TABLE 283. ITALY COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
• TABLE 284. ITALY COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 285. ITALY COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
• TABLE 286. ITALY COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
• TABLE 287. ITALY COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 288. ITALY COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 289. NETHERLANDS COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 290. NETHERLANDS COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 291. NETHERLANDS COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
• TABLE 292. NETHERLANDS COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
• TABLE 293. NETHERLANDS COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 294. NETHERLANDS COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
• TABLE 295. NETHERLANDS COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
• TABLE 296. NETHERLANDS COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 297. NETHERLANDS COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 298. NIGERIA COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 299. NIGERIA COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 300. NIGERIA COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
• TABLE 301. NIGERIA COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
• TABLE 302. NIGERIA COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 303. NIGERIA COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
• TABLE 304. NIGERIA COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
• TABLE 305. NIGERIA COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 306. NIGERIA COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 307. NORWAY COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 308. NORWAY COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 309. NORWAY COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
• TABLE 310. NORWAY COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
• TABLE 311. NORWAY COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 312. NORWAY COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
• TABLE 313. NORWAY COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
• TABLE 314. NORWAY COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 315. NORWAY COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 316. POLAND COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 317. POLAND COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 318. POLAND COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
• TABLE 319. POLAND COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
• TABLE 320. POLAND COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 321. POLAND COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
• TABLE 322. POLAND COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
• TABLE 323. POLAND COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 324. POLAND COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 325. QATAR COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 326. QATAR COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 327. QATAR COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
• TABLE 328. QATAR COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
• TABLE 329. QATAR COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 330. QATAR COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
• TABLE 331. QATAR COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
• TABLE 332. QATAR COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 333. QATAR COPD

The COPD & Asthma Devices Market was valued at USD 35.33 billion in 2023, expected to reach USD 37.45 billion in 2024, and is projected to grow at a CAGR of 5.93%, to USD 52.90 billion by 2030.

The COPD and asthma devices market encompasses medical devices and equipment designed for the diagnosis, treatment, and management of Chronic Obstructive Pulmonary Disease (COPD) and asthma. This includes inhalers, nebulizers, oxygen concentrators, and spirometry devices, which are essential for clinical and home-based settings. The necessity of these devices stems from the increasing prevalence of respiratory diseases due to factors like pollution, smoking, and an aging population. These devices are pivotal in efficiently administering medications, monitoring respiratory conditions, and improving the quality of life for patients. The growing awareness about respiratory health and advancements in medical technology drive demand in both developed and developing markets. Key growth factors include technological innovations such as smart inhalers and portable nebulizers, increasing healthcare expenditure, and supportive government policies promoting respiratory care. Latest opportunities lie in the integration of digital health technologies, which offer enhanced patient adherence and monitoring through apps and IoT-enabled devices. Manufacturers can capitalize on this by investing in R&D to create more user-friendly and connected devices that cater to tech-savvy patients. However, the market faces challenges such as high costs of advanced devices, stringent regulatory approvals, and limited access in lower-income regions. Additionally, the disparity in healthcare infrastructure could hinder market growth in emerging economies. Companies focusing on innovation must consider cost-effective manufacturing processes and seek partnerships to expand market reach to overcome these barriers. Research should also target enhancing device effectiveness and reducing side effects to meet patient-specific needs. The market remains competitive, with consolidation trends as companies seek to expand their product portfolios through mergers and acquisitions. Overall, the industry continues evolving, with ample scope for development in patient-centered and digital innovations, which present lucrative opportunities for growth in the COPD and asthma devices market.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving COPD & Asthma Devices Market

The COPD & Asthma Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Government initiatives and policies supporting respiratory disease management and treatment
  • Emerging markets creating new opportunities for respiratory device manufacturers through enhanced healthcare access
  • Improved patient adherence to respiratory therapies driven by user-friendly and portable device designs
  • Rising environmental pollution exacerbating respiratory conditions and increasing demand for treatment devices
• Market Restraints
  • Lack of standardization in COPD & asthma device manufacturing affecting product consistency
  • Challenges in educating healthcare providers about the latest COPD & asthma device advancements
• Market Opportunities
  • Rise of personalized medicine approaches in COPD and asthma treatment protocols
  • Growth in patient education and self-management programs to reduce asthma-related hospitalizations
  • Innovative drug delivery systems enhancing medication adherence in COPD treatments
• Market Challenges
  • Complications in ensuring patient adherence and compliance with prescribed treatment regimens
  • Limited healthcare access in rural and underserved areas

Porter's Five Forces: A Strategic Tool for Navigating the COPD & Asthma Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the COPD & Asthma Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the COPD & Asthma Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the COPD & Asthma Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the COPD & Asthma Devices Market

A detailed market share analysis in the COPD & Asthma Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the COPD & Asthma Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the COPD & Asthma Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the COPD & Asthma Devices Market

A strategic analysis of the COPD & Asthma Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the COPD & Asthma Devices Market, highlighting leading vendors and their innovative profiles. These include 3M Health Care, Aerogen, Air Liquide Healthcare, Becton, Dickinson and Company, Chart Industries, Drive DeVilbiss Healthcare, Fisher & Paykel Healthcare, Getinge, GF Health Products, Inc., Hamilton Medical, Invacare Corporation, Koninklijke Philips N.V., Medtronic, Nihon Kohden Corporation, PARI Medical Holding, ResMed, Smiths Medical, SunMed, and Teleflex Incorporated.

Market Segmentation & Coverage

This research report categorizes the COPD & Asthma Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product Type, market is studied across Accessories, Inhalers, and Nebulizers. The Accessories is further studied across Actuators, Dry Powder Inhaler Rotacaps & Cartridges, and Spacers. The Inhalers is further studied across Dry Powder Inhalers (DPI), Metered-Dose Inhalers (MDI), and Soft Mist Inhalers. The Nebulizers is further studied across Jet Nebulizers, Mesh Nebulizers, and Ultrasonic Nebulizers.
• Based on Application, market is studied across Asthma and Chronic Obstructive Pulmonary Disease (COPD). The Asthma is further studied across Allergic Asthma, Exercise-Induced Asthma, and Non-Allergic Asthma. The Chronic Obstructive Pulmonary Disease (COPD) is further studied across Chronic Bronchitis and Emphysema.
• Based on End-User, market is studied across Ambulatory Surgical Centers, Homecare Settings, Hospitals & Clinics, and Specialty Clinics.
• Based on Distribution Channel, market is studied across Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Government initiatives and policies supporting respiratory disease management and treatment
    • 5.1.1.2. Emerging markets creating new opportunities for respiratory device manufacturers through enhanced healthcare access
    • 5.1.1.3. Improved patient adherence to respiratory therapies driven by user-friendly and portable device designs
    • 5.1.1.4. Rising environmental pollution exacerbating respiratory conditions and increasing demand for treatment devices
  • 5.1.2. Restraints
    • 5.1.2.1. Lack of standardization in COPD & asthma device manufacturing affecting product consistency
    • 5.1.2.2. Challenges in educating healthcare providers about the latest COPD & asthma device advancements
  • 5.1.3. Opportunities
    • 5.1.3.1. Rise of personalized medicine approaches in COPD and asthma treatment protocols
    • 5.1.3.2. Growth in patient education and self-management programs to reduce asthma-related hospitalizations
    • 5.1.3.3. Innovative drug delivery systems enhancing medication adherence in COPD treatments
  • 5.1.4. Challenges
    • 5.1.4.1. Complications in ensuring patient adherence and compliance with prescribed treatment regimens
    • 5.1.4.2. Limited healthcare access in rural and underserved areas
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. COPD & Asthma Devices Market, by Product Type

• 6.1. Introduction
• 6.2. Accessories
  • 6.2.1. Actuators
  • 6.2.2. Dry Powder Inhaler Rotacaps & Cartridges
  • 6.2.3. Spacers
• 6.3. Inhalers
  • 6.3.1. Dry Powder Inhalers (DPI)
  • 6.3.2. Metered-Dose Inhalers (MDI)
  • 6.3.3. Soft Mist Inhalers
• 6.4. Nebulizers
  • 6.4.1. Jet Nebulizers
  • 6.4.2. Mesh Nebulizers
  • 6.4.3. Ultrasonic Nebulizers

7. COPD & Asthma Devices Market, by Application

• 7.1. Introduction
• 7.2. Asthma
  • 7.2.1. Allergic Asthma
  • 7.2.2. Exercise-Induced Asthma
  • 7.2.3. Non-Allergic Asthma
• 7.3. Chronic Obstructive Pulmonary Disease (COPD)
  • 7.3.1. Chronic Bronchitis
  • 7.3.2. Emphysema

8. COPD & Asthma Devices Market, by End-User

• 8.1. Introduction
• 8.2. Ambulatory Surgical Centers
• 8.3. Homecare Settings
• 8.4. Hospitals & Clinics
• 8.5. Specialty Clinics

9. COPD & Asthma Devices Market, by Distribution Channel

• 9.1. Introduction
• 9.2. Hospital Pharmacies
• 9.3. Online Pharmacies
• 9.4. Retail Pharmacies

10. Americas COPD & Asthma Devices Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific COPD & Asthma Devices Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa COPD & Asthma Devices Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. 3M Health Care
• 2. Aerogen
• 3. Air Liquide Healthcare
• 4. Becton, Dickinson and Company
• 5. Chart Industries
• 6. Drive DeVilbiss Healthcare
• 7. Fisher & Paykel Healthcare
• 8. Getinge
• 9. GF Health Products, Inc.
• 10. Hamilton Medical
• 11. Invacare Corporation
• 12. Koninklijke Philips N.V.
• 13. Medtronic
• 14. Nihon Kohden Corporation
• 15. PARI Medical Holding
• 16. ResMed
• 17. Smiths Medical
• 18. SunMed
• 19. Teleflex Incorporated